Wolverine Trading
CORV

Wolverine Trading’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Wolverine Trading’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Hold
0
– – – 5998
2017
Q2 		– Sell
-11,247
Closed -$40.8K – 5865
2017
Q1 		$34K Sell
11,247
-11,705
-51% -$34.5K ﹤0.01% 4053
2016
Q4 		$63K Sell
22,952
-197
-0.9% -$563 ﹤0.01% 4175
2016
Q3 		$72K Buy
23,149
+11,118
+92% +$40.5K ﹤0.01% 4313
2016
Q2 		$61K Buy
+12,031
New +$57.8K 0.01% 3784

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.4M AUM 49.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return